PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
Robotics Welcome
Natan Linder, Founder, Tulip
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Trond Undheim, PhD, Program Director, MIT Startup Exchange in collaboration with Anne Deconinck, PhD, Executive Director, MIT Koch Institute for Integrative Cancer Research
Alan Kriz - Open Innovation and Investment
John Andrews, CEO, Celect
Sanjay Manandhar, Aerva Founder & CEO